OSCO is the only professional organization that represents all oncologists, oncology nurses and oncology practices in Oklahoma. Joining OSCO gives you access to shared member resources, provides CME opportunities, and more.
BESPONSA™-Effective for dates of service on or after January 1, 2018, the Centers for Medicare and Medicaid Services (CMS) has granted BESPONSA™ (inotuzumab ozogamicin) injection for IV infusion the following ... Read More
Most Recent FDA Drug Approvals
Acalabrutinib-U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.